Definium Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Definium Therapeutics, Inc. (DFTX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $9.64M, a 83.50% increase year-over-year.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $7.13M, a 108.17% increase year-over-year.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.82M, a 51.42% increase year-over-year.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.25M, a 3.26% decline year-over-year.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $20.10M, a 18.82% increase from fiscal 2024.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $16.91M, a 11.39% increase from fiscal 2023.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $15.18M, a 11.12% increase from fiscal 2022.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $13.66M, a 63.10% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.64M 10-Q · filed 2026-08-06 | $16.77M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $7.13M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $20.10M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $5.82M 10-Q · filed 2025-11-06 | $11.07M derived: sum of 2 quarters · filed 2026-08-06 | $14.49M derived: sum of 3 quarters · filed 2026-08-06 | $18.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $5.25M 10-Q · filed 2026-08-06 | $8.68M derived: sum of 2 quarters · filed 2026-08-06 | $12.63M derived: sum of 3 quarters · filed 2026-08-06 | $16.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.43M 10-Q · filed 2026-08-06 | $7.38M derived: sum of 2 quarters · filed 2026-08-06 | $11.22M derived: sum of 3 quarters · filed 2026-08-06 | $16.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.79M derived: sum of 2 quarters · filed 2026-02-26 | $13.22M derived: sum of 3 quarters · filed 2026-02-26 | $16.91M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.84M 10-Q · filed 2025-11-06 | $9.27M derived: sum of 2 quarters · filed 2025-11-06 | $12.96M 10-Q · filed 2024-11-07 | $16.53M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $5.43M 10-Q · filed 2025-11-06 | $9.12M 10-Q · filed 2024-08-13 | $12.69M derived: sum of 3 quarters · filed 2025-11-06 | $16.89M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-03-31 | $3.69M 10-Q · filed 2025-11-06 | $7.26M derived: sum of 2 quarters · filed 2025-11-06 | $11.46M derived: sum of 3 quarters · filed 2025-11-06 | $15.23M derived: sum of 4 quarters · filed 2025-11-06 |
| 2023-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $7.78M derived: sum of 2 quarters · filed 2025-03-06 | $11.54M derived: sum of 3 quarters · filed 2025-03-06 | $15.18M 10-K · filed 2025-03-06 |
| 2023-09-30 | $4.20M 10-Q · filed 2024-11-07 | $7.96M derived: sum of 2 quarters · filed 2024-11-07 | $11.61M 10-Q · filed 2024-11-07 | $13.01M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.76M 10-Q · filed 2024-08-13 | $7.41M 10-Q · filed 2024-08-13 | $8.80M derived: sum of 3 quarters · filed 2024-08-13 | $13.09M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $3.65M 10-Q · filed 2024-05-08 | $5.04M derived: sum of 2 quarters · filed 2024-05-08 | $9.33M derived: sum of 3 quarters · filed 2024-05-08 | $13.50M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.68M derived: sum of 2 quarters · filed 2024-02-28 | $9.86M derived: sum of 3 quarters · filed 2024-02-28 | $13.66M 10-K · filed 2024-02-28 |
| 2022-09-30 | $4.29M 10-Q · filed 2023-11-02 | $8.46M derived: sum of 2 quarters · filed 2023-11-02 | $12.27M 10-Q · filed 2023-11-02 | $15.98M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $4.17M 10-Q · filed 2023-08-03 | $7.98M 10-Q · filed 2023-08-03 | $11.69M derived: sum of 3 quarters · filed 2023-08-03 | $16.16M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $3.81M 10-Q · filed 2023-05-04 | $7.52M derived: sum of 2 quarters · filed 2023-05-04 | $11.99M derived: sum of 3 quarters · filed 2023-05-04 | $39.62M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $8.18M derived: sum of 2 quarters · filed 2023-03-09 | $35.81M derived: sum of 3 quarters · filed 2023-03-09 | $37.03M 10-K · filed 2023-03-09 |
| 2021-09-30 | $4.47M 10-Q · filed 2022-11-10 | $32.10M derived: sum of 2 quarters · filed 2022-11-10 | $33.31M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $27.63M 10-Q · filed 2022-08-11 | $28.84M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $1.21M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $1.59M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |